IQ-AI Limited (LON:IQAI – Get Free Report) shares rose 8.7% during mid-day trading on Tuesday . The stock traded as high as GBX 1.28 ($0.02) and last traded at GBX 1.25 ($0.02). Approximately 408,627 shares changed hands during trading, a decline of 45% from the average daily volume of 744,999 shares. The stock had previously closed at GBX 1.15 ($0.01).
IQ-AI Price Performance
The company has a debt-to-equity ratio of 8.80, a current ratio of 0.49 and a quick ratio of 1.01. The firm’s 50-day moving average is GBX 1.22 and its two-hundred day moving average is GBX 1.63. The company has a market cap of £2.77 million, a P/E ratio of -13.67 and a beta of 2.91.
IQ-AI Company Profile
IQ-AI Limited, through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services.
See Also
- Five stocks we like better than IQ-AI
- Top Biotech Stocks: Exploring Innovation Opportunities
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Receive News & Ratings for IQ-AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQ-AI and related companies with MarketBeat.com's FREE daily email newsletter.